VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis

Published:2014-11-13 Issue:3 Volume:35 Page:377-387
ISSN:0272-4340
Container-title:Cellular and Molecular Neurobiology
language:en
Short-container-title:Cell Mol Neurobiol

Author:

Dillingham Blythe C.,Knoblach Susan M.,Many Gina M.,Harmon Brennan T.,Mullen Amanda M.,Heier Christopher R.,Bello Luca,McCall John M.,Hoffman Eric P.,Connor Edward M.,Nagaraju Kanneboyina,Reeves Erica K. M.,Damsker Jesse M.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10571-014-0133-y.pdf

Reference81 articles.

1. Alt C, Laschinger M, Engelhardt B (2002) Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 32(8):2133–2144. doi: 10.1002/1521-4141(200208)32:8<2133

2. Arima Y, Harada M, Kamimura D, Park JH, Kawano F, Yull FE, Kawamoto T, Iwakura Y, Betz UA, Marquez G, Blackwell TS, Ohira Y, Hirano T, Murakami M (2012) Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148(3):447–457. doi: 10.1016/j.cell.2012.01.022

3. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr (1993) Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177(1):57–68

4. Baudy AR, Saxena N, Gordish H, Hoffman EP, Nagaraju K (2009) A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases. Int Immunopharmacol 9(10):1209–1214. doi: 10.1016/j.intimp.2009.07.001

5. Becher B, Durell BG, Miga AV, Hickey WF, Noelle RJ (2001) The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 193(8):967–974

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of different doses of vamorolone in boys with Duchenne muscular dystrophy: a systematic review and network meta-analysis;Frontiers in Neurology;2024-08-21

2. Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy;Journal of Neuromuscular Diseases;2023-11-07

3. Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy;touchREVIEWS in Neurology;2023

4. The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice;Journal of Neuromuscular Diseases;2021-11-30

5. Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple;Neurología;2021-05